Apex Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.00 Cr
- Revenue Growth %
- Ebitda 74.80%
- Net Worth -1.27%
- Total Assets 5.03%
About Apex Biotechnologies
Apex Biotechnologies Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 September 2004 and has a history of 20 years and four months. Its registered office is in Delhi, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gurupreet Sangla, Harvinder Singh, Ashok Wadia, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01409DL2004PTC129583
- Company No.
129583
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2004
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Apex Biotechnologies?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurupreet Sangla  | Director | 28-Jan-2022 | Current |
| Harvinder Singh | Director | 30-Sep-2004 | Current |
| Ashok Wadia | Director | 28-Jan-2022 | Current |
| Ishita Wadia | Director | 11-Feb-2023 | Current |
Financial Performance of Apex Biotechnologies.
Apex Biotechnologies Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apex Biotechnologies?
In 2018, Apex Biotechnologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dwarkadhish Realtors Private LimitedGurupreet Sangla, Harvinder Singh and 1 more are mutual person
Baba Ventures Private LimitedHarvinder Singh is a mutual person
Baba Multimedia Private LimitedGurupreet Sangla and Harvinder Singh are mutual person
Rishabglobal Industries Private LimitedIshita Wadia is a mutual person
Goa Coastal Resorts And Recreation Private LimitedAshok Wadia and Ishita Wadia are mutual person
Uphill Farms Private LimitedGurupreet Sangla and Harvinder Singh are mutual person
Charges (Loans)
₹0
₹30.00 M
Charges Breakdown by Lending Institutions
- Syndicate Bank : 3.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2008 | Syndicate Bank | ₹3.00 Cr | Satisfied |
How Many Employees Work at Apex Biotechnologies?
Unlock and access historical data on people associated with Apex Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
